ArticleViruses2021

Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma.

Shariful Islam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.